GlassScriptPhysician profile
Alan R Sacolick
NPI 1790784783
$1,475.80
in general payments reported to CMS, 2019-2025
19 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $179 · 2021: $107 · 2022: $48.43 · 2023: $495 · 2024: $288 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $869 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $868.74 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $427.43 | 2019-2025 | Ubrelvy, Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $271.38 | 2022-2025 | Veozah |
| Minerva Surgical, INC | $258.77 | 2020-2024 | |
| Mayne Pharma Commercial LLC | $97.55 | 2023-2025 | |
| Applied Medical Resources Corporation | $81.75 | 2020 | |
| Merck Sharp & Dohme LLC | $43.69 | 2022-2023 | Gardasil 9 |
| Coopersurgical, INC. | $37.50 | 2019-2024 | Paragard T 380a |
| Kowa Pharmaceuticals America, INC. | $33.96 | 2023 | Seglentis |
| Meditrina | $27.74 | 2020 | |
| Therapeuticsmd, INC. | $26.29 | 2019 | |
| Channel Medsystems, INC. | $25.02 | 2024 | |
| Millicent US INC | $24.14 | 2024 | Intrarosa |
| Allergan, INC. | $23.55 | 2019-2020 | |
| Agile Therapeutics, INC. | $19.17 | 2021 | |
| Gynesonics, INC. | $18.04 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $17.50 | 2021 | |
| Pfizer INC. | $15.23 | 2025 | |
| Biogen, INC. | $13.89 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $13.20 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Sacolick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.